Vivek Charu

Background: Current non-invasive tests (NITs) utilized to screen and predict liver fibrosis were developed in predominantly Caucasian populations, and their performance in non-Caucasians is not well known…

Background: In the United States, patients with early-stage hepatocellular carcinoma (HCC) listed for liver transplant (LT) receive MELD exception points on the waiting list, as they often do not generate a laboratory MELD score to be competitive for LT…